Carbapenemase-producing
gram-negative Microorganisms.
Where are we now?
Challenges in prevention, diagnosis,
detection and therapy.
Thursday 4 June 2015
Royal College of Physicians, London
CPD ACCREDITED
Welcome
Carbapenemase-producing Gram-negatives have become a major concern worldwide.
Many factors, including the ease of international travel for medical tourism and
migration and the importation of food products, have been responsible for introducing
these microorganisms to several countries far beyond their country of origin.
These organisms cause serious infections in hospitalised patients and are associated
with increased mortality. Carbapenemase-producing Gram-negatives exhibit extensive
drug-resistant phenotypes, complicate therapy and limit treatment options. Strict
infection control measures, including active surveillance for timely detection of
colonised patients, are some of the only effective ways of preventing the introduction
and transmission of these bacteria in healthcare settings.
This meeting will be of interest to microbiologists, infectious disease physicians,
pharmacists, scientists, infection control specialists, colleagues in industry and
professionals allied to the field of infection and antimicrobial chemotherapy.
This meeting has generated considerable interest, even prior to the programme being
fully confirmed; early booking is therefore highly recommended.
Professor Dilip Nathwani OBE
BSAC President Dr Brendan Healy
BSAC Meetings Secretary
Call for abstracts for poster presentation
Abstracts are invited, in particular from junior investigators and trainees who are
encouraged to attend and submit abstracts for consideration for poster presentation.
Submission forms are available from the BSAC website. The deadline for receipt of
poster abstract submissions is Friday 1 May 2015.
Programme
0900
Registration & coffee
0950
Welcome & introductory remarks
Professor Dilip Nathwani OBE, BSAC President
SESSION ONE: Social and clinical impact
Chair: Professor Dilip Nathwani OBE, Consultant Physician, Ninewells Hospital, Dundee
1000
Setting the Carbapenemase scene: The impact on public, political and media psyche
Professor Tim Walsh, Professor of Medical Microbiology & Antimicrobial Resistance, Cardiff
1020
Invited guest lecture
Carbapenamases: Global and UK Epidemiology; Now and the future
Professor Neil Woodford, Head, Antimicrobial Resistance & Healthcare Associated Infections Reference Unit (AMRHAI), PHE London
1050
1115
Panel discussion
SESSION TWO: Prevention, detection and screening
Chair: Professor Kate Gould, Honorary Consultant Microbiologist, Newcastle upon Tyne 1145
1205
What’s new in prevention?
Professor Peter Wilson, Consultant Microbiologist, UCLH NHS Foundation Trust
1225
Laboratory detection of carbapenemase-producers
Professor John Perry, Clinical Scientist, Newcastle
1245
Launch of Standard Microbiological Investigation for CRE detection
Dr Albert Mifsud, Chair, Bacteriology Working Group of the Standards for Microbiological Investigations
1255 Panel discussion
1315
LUNCH, EXHIBITION & POSTER VIEWING
SESSION THREE: Treatment, stewardship and surveillance
Chair: Dr Nick Brown, Consultant Microbiologist, Addenbrookes Hospital, Cambridge
1415
How to treat Carbapenemase: Current treatment options, strengths and pitfalls and potential role of future drugs
Dr Anastasia Antoniadou, University of Athens, Greece
1445
Stewardship – is there a role for a “carbapenem sparing strategy”?
Professor Dilip Nathwani OBE, Consultant Physician, Ninewells Hospital, Dundee
1505
What next? Implementation of a national surveillance system for carbapenem resistance
Dr Rachel Freeman, Field Epidemiology Training Programme Fellow , PHE London
1525
Panel discussion
1545
Closing remarks
Professor Dilip Nathwani OBE, BSAC President
COFFEE, EXHIBITION & POSTER VIEWING
Molecular resistance and diagnosis
Dr Matthew Ellington, Public Health England
Carbapenemase-producing Gram-negative Microorganisms.
Where are we now?
Challenges in prevention, diagnosis, detection and therapy.
Thursday 4 June 2015, Royal College of Physicians, London
REGISTRATION FORM Please complete ALL SECTIONS in BLOCK capitals
Title:
First name:
Surname:
Job Title:
Department:
Institute name & address:
Tel:
Postcode:
Fax:
Email:
From time to time we would like to email you with information about BSAC activities which we believe will be of interest to you. This will
not involve your details being passed to any third party and you can unsubscribe at any time. If you would prefer NOT to receive this
information please tick the box.
No, I would prefer not to receive information from the BSAC
REGISTRATION FEES (inclusive of VAT)
PAYMENT DETAILS
(please tick)
BSAC Members (NHS) £95.00
Cheque payable to BSAC enclosed
BSAC Members (commercial) £180.00
Non BSAC Members (NHS) £130.00
charge to credit/debit card
Trainees (BSAC Members) £45.00
(please indicate card number, expiry date and security number)
Trainees (Non BSAC Members) £75.00
Students £35.00
Industry/commercial £295.00
MASTERCARD
VISA
SWITCH
Payment in Sterling should be made to BSAC as follows:
EUROCARD
SECURITY NO
SOLO
ELECTRON
ISSUE NO
switch only
CARD
NUMBER
START DATE
EXPIRY DATE
CARDHOLDER’S NAME
CARDHOLDER’S HOME ADDRESS
I authorise the use of my credit card for this purpose
Signature
Date
CANCELLATION POLICY
No refunds will be given for
cancellation notified on or after
Friday 8 May 2015
Please complete all sections
and return to:
Esme Carruthers
Event Coordinator
BSAC, Griffin House
53 Regent Place
Birmingham B1 3NJ
Tel: +44 (0) 121 236 1988
Email: [email protected]
Website: www.bsac.org.uk